Skip to content
DataLookout
Menu

SYVIPRONCT07503821

Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved at least 6 months later across 2 updates.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 10 words
    • Primary and study completion pushed from Sep 2030 to Oct 30, 2030
    • Start date changed from estimate of Sep 2026 to Oct 30, 2026
    • Secondary endpoints: details revised at 1 of 4 entries
  2. Notable Recruitment openedv2 Show 4 more changesShow less
    • Start date: Apr 2026 to Sep 2026
    • Eligibility criteria shortened, about 1 word
    • Primary and study completion pushed from Apr 2030 to Sep 2030
    • Site details revised at 3 of 3 sites
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

number of samples
Timeframe: 1 day

Secondary (4)

Tissue quality
number of adverse events
Patient acceptability
Cluster analysis of results from high-throughput experiments

Arms and interventions

Synovial samplingExperimental

Synovial sampling on first visit

Procedures: synovial biopsy

Sites

3 sites in 1 country